EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS ‐ COV ‐2 and lung adenocarcinoma crosstalk genes

Yanan Wu, Yishuang Cui, Xuan Zheng, Xuemin Yao, Guogui Sun iD

Cancer Science · 2025

DOI: 10.1111/cas.16384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Yanan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: COVID-19, Adenocarcinoma of Lung, Machine Learning, Lung Neoplasms. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viruses are widely recognized to be intricately associated with both solid and hematological malignancies in humans. The primary goal of this research is to elucidate the interplay of genes between SARS‐CoV‐2 infection and lung adenocarcinoma (LUAD), with a preliminary investigation into their clinical significance and underlying molecular mechanisms. Transcriptome data for SARS‐CoV‐2 infection and LUAD were sourced from public databases. Differentially expressed genes (DEGs) associated with SARS‐CoV‐2 infection were identified and subsequently overlapped with TCGA‐LUAD DEGs to discern the crosstalk genes (CGs). In addition, CGs pertaining to both diseases were further refined using LUAD TCGA and GEO datasets. Univariate Cox regression was conducted to identify genes associated with LUAD prognosis, and these genes were subsequently incorporated into the construction of a prognosis signature using 10 different machine learning algorithms. Additional investigations, including tumor mutation burden assessment, TME landscape, immunotherapy response assessment, as well as analysis of sensitivity to antitumor drugs, were also undertaken. We discovered the risk stratification based on the prognostic signature revealed that the low‐risk group demonstrated superior clinical outcomes ( p < 0.001). Gene set enrichment analysis results predominantly exhibited enrichment in pathways related to cell cycle. Our analyses also indicated that the low‐risk group displayed elevated levels of infiltration by immunocytes ( p < 0.001) and superior immunotherapy response ( p < 0.001). In our study, we reveal a close association between CGs and the immune microenvironment of LUAD. This provides preliminary insight for further exploring the mechanism and interaction between the two diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Adenocarcinoma of LungMachine LearningLung NeoplasmsSARS-CoV-2HumansPrognosisTranscriptomeGene Expression Regulation, NeoplasticTumor MicroenvironmentGene Expression ProfilingBiomarkers, Tumor

Stichwörter der Autor:innen

SARS‐CoV‐2 infectionbioinformatics analysisimmune cell infiltrationlung adenocarcinomatranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Public Health, North China University of Science and Technology, Tangshan, China.

ORCID-Profile: Guogui Sun

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Wu, Y., Cui, Y., Zheng, X., Yao, X., & Sun, G. (2025). Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS ‐ COV ‐2 and lung adenocarcinoma crosstalk genes. Cancer Science. https://doi.org/10.1111/cas.16384

Vancouver

Wu Y, Cui Y, Zheng X, Yao X, Sun G. Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS ‐ COV ‐2 and lung adenocarcinoma crosstalk genes. Cancer Science. 2025. doi:10.1111/cas.16384

BibTeX
@article{Wu2025,
  author = {Wu, Yanan and Cui, Yishuang and Zheng, Xuan and Yao, Xuemin and Sun, Guogui},
  title = {Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS ‐ COV ‐2 and lung adenocarcinoma crosstalk genes},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.16384}
}
Kostenlos starten →